Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc

Wednesday, August 6, 2008 General News J E 4
WHIPPANY, N.J., Aug. 5 Nexgen Spine, a leading developerof innovative spinal implants for the surgical treatment of degenerative discdisease, announced today that it has received CE mark approval to market thePhysio-L(R) Lumbar Artificial Disc in the European Union.

"We are delighted that the Physio-L(R) Artificial Disc Prosthesis hasreceived CE mark approval," said Alastair Clemow, Ph.D., President and CEO ofNexgen Spine. "This represents an important milestone in our plan to launch afull range of artificial disc prostheses based on our proprietary elastomericdisc technology." Dr. Clemow further added, "the fact that the Physio-L(R) isthe first of the next generation elastomeric lumbar discs to receive a CE markmakes this approval even more exciting."

The Physio-L(R) Artificial Disc is an elastomeric disc prosthesis designedto be used in the lumbar spine for patients suffering from degenerative discdisease. The device's proprietary elastomeric technology enables the disc toclosely mimic the mechanical properties of the natural disc and represents asignificant advance over current designs of disc prostheses.

"The unique properties of the Physio-L(R) help restore the natural shockabsorption of the disc," said Casey Lee MD, Chairman and Founder of NexgenSpine. "This allows the surgeon to restore function to the patient's disc.The clinical data for the Physio-L(R) are demonstrating outstandingimprovements in both patient disability and pain, supporting the concept ofusing elastomeric polymers for total disc prostheses."

Nexgen Spine, Inc. is dedicated to providing its customers with highquality products that promote pain relief, preservation of motion andrestoration of function by applying state-of-the-art design, biomaterials, andmanufacturing technology. The company, based in Whippany NJ, is ISO13485:2003 certified.

Contact: Alastair Clemow, President & CEO at 973-386-1800 ext 302(

SOURCE Nexgen Spine


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Immucor Closes BioArray Acquisition
Jesse Milan to Address 2008 International AIDS Con...